Promising early results have been put on the back burner despite renewed global concern following a deadly cruise ship ...
Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising ...
With no approved vaccine for the fast-growing Ebola outbreak in the DRC, experts weigh testing one with unknown protection.
A hantavirus vaccine is currently in preclinical development, but a publicly available shot is likely years away. Other ...
But it has been hard to attract interest in medical interventions for viruses that have not been considered a top public ...
Clinical trials for treatments against Ebola Bundibugyo virus are ‘in a strong position’ to be launched quickly in the ...
Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.
The Democratic Republic of Congo faces a severe Ebola outbreak fueled by the rare Bundibugyo strain, prompting an urgent need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results